cardiovascular disease

Bagsværd, Denmark, September 16, 2026 Novo Nordisk has announced that it will present new clinical and real-world evidence spanning...

Waltham, Massachusetts, U.S., September 16, 2026 Skyhawk Therapeutics has announced final 15-month results from its Phase 1/2 clinical trial...

MIAMI — September 16, 2026 Longeveron Inc. announced topline results from its Phase 2b ELPIS II clinical trial evaluating...

Seattle, Washington, U.S., September 15, 2026 HDT Bio Corp. has received an ARPA-H GIVE award to lead the development...

WALTHAM, Mass. and BOULDER, Colo. — September 15, 2026 Cogent Biosciences, Inc. announced that the U.S. Food and Drug...

Toronto, Ontario, Canada, September 16, 2026 Thryv Therapeutics has announced the publication of new research in JACC: Heart Failure...

BOSTON — September 15, 2026 Vertex Pharmaceuticals Incorporated announced a partnership with world champion skier Lindsey Vonn to raise...

PASADENA, Calif. — September 15, 2026 Arrowhead Pharmaceuticals, Inc. announced interim topline clinical data from the Phase 1/2a ARODIMER-PA-1001...

BERLIN — September 9, 2026 Bayer announced the initiation of a global Phase II clinical trial of BAY 3670549,...

Carlsbad, California — September 4, 2026 Ionis Pharmaceuticals and partner Novartis reported topline results from the Phase 3 Lp(a)HORIZON...